Fact CheckerSign in

NCT05748028Recruiting

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms: Identification of Predictive Patterns of Rehabilitation Outcome and Evaluation of the Impact on Quality of Life

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

The goal of this observational study is to learn about the impact of the different types of pain and of the domains involved in the autonomic disorders of inpatients and outpatients diagnosed with Parkinson disease (PD) and multiple system atrophy (MSA) admitted to Istituti Clinici Scientifici Maugeri Centers. The main aims are: Evaluate the prevalence of pain and characterize it in Parkinson's disease and atypical parkinsonisms (MSA) Evaluate the effect of rehabilitation on pain and autonomic symptoms Evaluate the prevalence of autonomic symptoms in Parkinson's disease and atypical parkinsonisms (MSA) Assess the impact of pain and autonomic symptoms on quality of life. Participants will perform neurological examination, rehabilitation program and clinical scales. Researchers will compare the two groups of patients (PD and MSA) and the effect of the rehabilitation on pain, autonomic symptoms and quality of life.

Status (registry)
Recruiting
Study type
Observational
Enrollment
280 (estimated)
First submitted
26 Jan 2023
Start date
15 Jun 2019
Primary completion date
30 Sept 2026
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
NCT number
NCT05748028

What you commit to

  • Study type: Observational
  • Planned participants: 280
  • From 15 Jun 2019 to the primary completion date, 30 Sept 2026
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • assumption of potentially neurotoxic drugs

Other illness

  • diabetes mellitus

Other

  • vascular or pharmacological parkinsonism
  • hepatic or renal dysmetabolism,
  • hypothyroidism or hyperthyroidism

Who the study is looking for

  • Clinical diagnosis of Parkinson's Disease or Multiple System Atrophy according to current international criteria (Gilman S et al, 2008; Postuma RB et al. 2015).
  • Mini-Mental State Examination score at least 10

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
ICS Maugeri - Castelgoffredo
Coordinator of this site? Confirm its status
Castel GoffredoItalyRecruiting
ICS Maugeri - Lumezzane
Coordinator of this site? Confirm its status
LumezzaneItalyRecruiting
ICS Maugeri - Milano
Coordinator of this site? Confirm its status
MilanItalyRecruiting
ICS Maugeri - Mistretta
Coordinator of this site? Confirm its status
MistrettaItalyRecruiting
ICS Maugeri - Montescano
Coordinator of this site? Confirm its status
MontescanoItalyRecruiting
ICS Maugeri - Pavia
Coordinator of this site? Confirm its status
PaviaItalyRecruiting
ICS Maugeri - Pavia Boezio
Coordinator of this site? Confirm its status
PaviaItalyRecruiting
ICS Maugeri - IRCCS of Telese Terme
Coordinator of this site? Confirm its status
Telese TermeItalyRecruiting
ICS Maugeri - Veruno
Coordinator of this site? Confirm its status
VerunoItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.